Relapses and disease-modifying drug treatment in pregnancy and live birth in US women with MS

OBJECTIVE: To evaluate relapse rates and disease-modifying drug (DMD) treatment in US women with multiple sclerosis (MS) and a live birth. METHODS: This retrospective administrative claims database study used US commercial health plan data from women with MS and a live birth from January 1, 2006, to...

Descripción completa

Detalles Bibliográficos
Autores principales: Houtchens, Maria K., Edwards, Natalie C., Phillips, Amy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205686/
https://www.ncbi.nlm.nih.gov/pubmed/30266887
http://dx.doi.org/10.1212/WNL.0000000000006382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205686/
https://www.ncbi.nlm.nih.gov/pubmed/30266887
http://dx.doi.org/10.1212/WNL.0000000000006382

Ejemplares similares